Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations

Clinical trial NCT01014052 · COMPLETED

Trial details

NCT number: NCT01014052
Sponsor: QLT Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

LCA (Leber Congenital Amaurosis)RP (Retinitis Pigmentosa)

Start date: 2009-11-01
Primary completion: 2012-08-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.